Ron Bentsur - Jul 20, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Jul 20, 2023
Transactions value $
$4,998
Form type
4
Date filed
7/24/2023, 04:45 PM
Previous filing
Jul 20, 2023
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1.66K +110 +0% $15.06 3.23M Jul 20, 2023 Direct F1
transaction NVCT Common Stock Purchase $3.34K +225 +0.01% $14.85 3.23M Jul 21, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.
F2 Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.55 to $15.14. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.